Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Mérédis Favreau
Profile
Projects
Publications
Activities
Awards & Distinctions
7
Results
2018
Checkpoint inhibition in the treatment of multiple myeloma : a way to boost innate-like T cell anti-tumor function?
Koen Venken
Mérédis Favreau
Djoere Gaublomme
Eline Menu
Karin Vanderkerken
Dirk Elewaut
A1
Journal Article
in
MOLECULAR IMMUNOLOGY
2018
2017
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
Mérédis Favreau
Koen Venken
Sylvia Faict
Ken Maes
Kim De Veirman
Elke De Bruyne
Xavier Leleu
Louis Boon
Dirk Elewaut
Karin Vanderkerken
et al.
A1
Journal Article
in
HAEMATOLOGICA
2017
Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
Nathan De Beule
Eline Menu
Mathieu Bertrand
Mérédis Favreau
Elke De Bruyne
Ken Maes
Kim De Veirman
Magdalena Radwanska
Afshin Samali
Stefan Magez
et al.
A1
Journal Article
in
ONCOTARGET
2017
Immune therapy in multiple myeloma : can iNKT cells be targeted?
Mérédis Favreau
Eline Menu
Karin Vanderkerken
Dirk Elewaut
Koen Venken
Dissertation
2017
Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma
Mérédis Favreau
E Menu
Djoere Gaublomme
K Vanderkerken
S Faict
K Maes
E De Bruyne
Srinath Govindarajan
Michael Drennan
Serge Van Calenbergh
et al.
A1
Journal Article
in
LEUKEMIA
2017
2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
Mérédis Favreau
Karin Vanderkerken
Dirk Elewaut
Koen Venken
Eline Menu
A1
Journal Article
in
ONCOTARGET
2016
2013
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model
Haneen Nur
Karel Fostier
SANDRINE ASPESLAGH
Wim Renmans
Elisabeth Bertrand
Xavier Leleu
Mérédis Favreau
Karine Breckpot
Rik Schots
Marc De Waele
et al.
A1
Journal Article
in
PLOS ONE
2013